Grants
Cycle 3: Alzheimer’s Drug Discovery Foundation
LOI DUE JULY 31, 2017 Preclinical Drug Discovery Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of resea...
July 31 atFoundation for Physical Therapy
DUE AUGUST 3, 2017, NOON EDT Foundation Research Grant Funds clinically relevant research by emerging investigators seeking to evaluate the effectiveness of physical therapy interventions. This grant will provide $40,000 for either one or two year pr...
August 3 atCycle 2: Ruth L. Kirschstein National Research Service Awards (F Series)
Sponsor: National Institutes of Health Due Date: August 8, 2017 Award: Fellowship
August 8 atCycle 2: Conference Grants (R13) and Conference Cooperative Agreements (U13)
Sponsor: NIH Due Date: August 12, 2017 Award: Funding for conferences
August 12 atCycle 1: BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42)
Sponsor: National Institutes of Health Due Date: September 5, 2017 by 5 pm local time of applicant Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awar...
September 5 atCycle 1: BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44)
Sponsor: National Institutes of Health Due Date: September 5, 2017 by 5 pm local time of applicant Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards...
September 5 atCycle 1: Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R43/R44)
Sponsor: National Institutes of Health Due Date: September 5, 2017 by 5 pm local time of applicant Award: Money, property, or both to an eligible entity to carry out an approved project or activity. Total funding support (direct costs, indirect cost...
September 5 atCycle 1: Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R41/R42)
Sponsor: National Institutes of Health Due Date: September 5, 2017 by 5 pm local time of applicant Award: Money, property, or both to an eligible entity to carry out an approved project or activity. Total funding support (direct costs, indirect costs...
September 5 atCycle 3: Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01)
Sponsor: NIH LOI Due Date: September 5, 2017 Due Date: October 5, 201 by 5 pm local time of applicant Award: Budgets for direct costs of up to $499,999 per year may be requested. Project period may not exceed 5 years.
September 5 atCycle 3: High Throughput Screening (HTS) to Discover Chemical Probes (R01)
Sponsor: National Institutes of Health LOI Due Date: September 5, 2017 Application Due Date: October 5, 2017 Award: Actual needs 3 years
September 5 atCycle 1: Small Business Innovation Research (SBIR)
Sponsor: National Institutes of Health Due Date: September 5, 2017 Award: Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III
September 5 atCycle 1: Small Business Technology Transfer (STTR)
Sponsor: National Institutes of Health Due Date: September 5, 2017 Award: Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III
September 5 atAES Seed Grant Program
Sponsor: American Epilepsy Society Due Date: September 22, 2017 Award: Seed Grants may provide up to $20,000 for one year for direct costs only, and they may not be renewed. Examples of allowable costs include research project supplies and expenses r...
September 22 atAES Seed Grant Program
Sponsor: American Epilepsy Society Due Date: September 22, 2017 Award: The AES Seed Grant Program provides support to established investigators to pursue new and innovative directions in epilepsy research, bring new research methods to their research...
September 22 atCycle 3: The Midlife in the United States Study (U19)
Sponsor: National Institutes of Health Due Date: September 25, 2017 by 5 pm local time of applicant organization Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. ...
September 25 at